Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for ClearPoint Neuro, Inc., €11k. Read the official filing
Filing timeline
BuySaleR. John Fletcher
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
R. John Fletcher: trading record in brief
R. John Fletcher is a declared insider at 3 companies (board member); the most frequent names are ClearPoint Neuro, Inc., KORU Medical Systems, Inc. and Vyant Bio, Inc. We count 58 filings; the first trade dates from 17 May 2021 and the latest from 1 October 2026.
On the market, this insider has only ever bought: 2 purchases, €129k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 53 share grants and 3 option exercises.
The latest filing, published on 2 October 2026, reports a share grant of €11k in ClearPoint Neuro, Inc. The most recent open-market purchase was published on 24 May 2021, 1,973 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to R. John Fletcher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations58 total
993 shares@ US$12.21Common StockSEC:0001193125-26-412424:0
7,679 shares@ US$2.930.015% mcap5.7% of flowCommon StockSEC:0001161697-26-000222:0
662 shares@ US$17.840.0026% mcap5.1% of flowCommon StockSEC:0001193125-26-296615:0
12,417 sharesCommon StockSEC:0001193125-26-234574:0
1,270 shares@ US$9.104.9% of flowCommon StockSEC:0001193125-26-139797:0
5,208 shares@ US$4.325.9% of flowCommon StockSEC:0001161697-26-000081:0
422 shares@ US$13.682.4% of flowCommon StockSEC:0001193125-26-002922:0
3,872 shares@ US$5.815.8% of flowCommon StockSEC:0001161697-26-000010:0
265 shares@ US$21.792.4% of flowCommon StockSEC:0001193125-25-228835:0
5,874 shares@ US$3.835.8% of flowCommon StockSEC:0001161697-25-000334:0
6,284 shares@ US$3.585.8% of flowCommon StockSEC:0001161697-25-000198:0
484 shares@ US$11.942.4% of flowCommon StockSEC:0000950170-25-093109:0
21,093 sharesCommon StockSEC:0000950170-25-074519:0
8,806 shares@ US$2.566.3% of flowCommon StockSEC:0001161697-25-000132:0
486 shares@ US$11.892.6% of flowCommon StockSEC:0000950170-25-049823:0
375 shares@ US$15.382.7% of flowCommon StockSEC:0000950170-25-001298:0
5,905 shares@ US$3.816.6% of flowCommon StockSEC:0001161697-25-000019:0
515 shares@ US$11.212.6% of flowCommon StockSEC:0001285550-24-000112:0
8,181 shares@ US$2.756.2% of flowCommon StockSEC:0001161697-24-000405:0
8,371 shares@ US$2.716.3% of flowCommon StockSEC:0001161697-24-000307:0
1,072 shares@ US$5.392.7% of flowCommon StockSEC:0001285550-24-000085:0
17,153 sharesCommon StockSEC:0001285550-24-000058:0
850 shares@ US$6.802.7% of flowCommon StockSEC:0001285550-24-000043:0
9,493 shares@ US$2.376.3% of flowCommon StockSEC:0001161697-24-000168:0
851 shares@ US$6.792.6% of flowCommon StockSEC:0001285550-24-000004:0
25 of 58 declarations
